Advanced Optics Electronics Inc. Files COLOR-CHEK Patent; A Potential Important Aid for the Vision Impaired.ALBUQUERQUE, N.M. -- Advanced Optics Electronics Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : ADOT ADOT Arizona Department Of Transportation ADOT Alaska Department of Transportation ADOT Fédération des Associations pour le Don d'Organes et de Tissus Humains ADOT Active Duty Other Than Training ADOT Automatic Digital Optical Tracker ADOT Advanced Display Optimization Tools ) ("ADOT") completed filing for its initial patent relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc its hand-held color check device known as COLOR-CHEK. The patent covers the company's unique and novel conception and implementation of hardware and firmware A category of memory chips that hold their content without electrical power. Firmware includes flash, ROM, PROM, EPROM and EEPROM technologies. When holding program instructions, firmware can be thought of as "hard software." See flash memory, ROM, PROM, EPROM, EEPROM and FOTA. systems for determining the color optically and expressing the result with vocal responses. This invention will initially benefit the vision impaired. ADOT is also developing a color coding kit to enhance the color check capabilities of a larger system of the color spectrum. Pricing is targeted in the $70-85 range. During the first half of 2005, ADOT will establish marketing arrangements for the distribution of the device after a supply has been manufactured and inventoried. Initial prototype models are being readied for viewing by the local media in the near future. Biomoda Inc. (30% directly and indirectly held by Advanced Optics Electronics) anticipates refiling its SB-2 within the next three weeks reflecting additional relationships as previously announced on the Biomoda Web site. Advanced Optics Electronics Inc. is a technology company based in Albuquerque, N.M. The company maintains an R&D facility and manufacturing plant, and is engaged in building large-scale flat panel displays A thin display screen for computer and TV usage. The first flat panels appeared on laptop computers in the mid-1980s, and the LCD technology became the standard. Stand-alone LCD screens became available for desktop computers in the mid-1990s and exceeded sales of CRTs for the first time utilizing its patented and patent-pending technology. In addition to the core business of ADOT, the company has made a strategic technology oriented investment in Biomoda Inc. Biomoda Inc. is a company that holds patents and patents pending domestically and internationally for the early detection of lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. . ADOT currently holds directly and indirectly 30% of Biomoda Inc. This news release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. that involve a high degree of risk and uncertainty. Such statements include, but are not limited to, statements containing the words "believes," "anticipates," "expects," "estimates," and words of similar import. The company's actual results could differ materially from any forward-looking statements, which reflect management's opinions only as of the date of this report, as a result of risks and uncertainties that exist in our operation, development efforts and business environment. The company undertakes no obligation to revise or publicly release the results of any revisions to these forward-looking statements. You should carefully review the risk factors in other documents that the company files from time to time with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. . |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion